Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21422434 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
Condition: Lung Cancer
Intervention: Biological: cetuximab

Indicates status has not been verified in more than two years